
............................
+ 2013
2012
2011
Archive
............................
Portfolio News
............................
New Leaf News
............................
|
 2013
Relypsa Completes Patient Enrollment
in Pivotal Phase 3 Program for the Treatment of Hyperkalemia
May 13, 2013
Pearl Therapeutics Initiates
PT003 Phase 3 Program for the Treatment of Individuals with
Moderate-to-Severe COPD
May 13, 2013
Concert
Pharmaceuticals Announces Strategic Collaboration with Celgene
Corporation to Develop Deuterium-Modified Compounds
May 6, 2013
Spine Wave Announces U.S. FDA’s 510K
Clearance of the StaXx® IB System, an Intervertebral Body Fusion Device
April 29, 2013
Durata Therapeutics Closes Public Offering of Common Stock
April 17, 2013
Chimerix Announces Pricing of Initial Public Offering
April 11, 2013
Oxford Immunotec wins 2013 Red
Herring Top 100 Award
April 11, 2013
MEI Pharma’s Mitochondrial Inhibitor
Drug Candidate ME-344 Delays Tumor Growth in Recurrent Ovarian Cancer
Model
April 10, 2013
iRhythm Secures $16 Million in
Funding Led by Norwest Venture Partners to Fuel Continued Market and
Technology Expansion
April 10, 2013
NxStage Completes Move to Direct Sales
In UK
April 8, 2013
MEI Pharma Announces $15.2 Million
Registered Offering of Common Stock
April 5, 2013
VaxInnate Awarded U.S. Government
Grant to Develop Dengue Vaccine
April 4, 2013
Array BioPharma Names Michael N.
Needle, M.D. As Chief Medical Officer
March 21, 2013
NeuroStar TMS Therapy, a
Non-Drug Depression Treatment, Demonstrates Statistically Significant
Benefits on Patient-Reported Pain Outcomes
March 19, 2013
Douglas Harrington, MD Addresses
Select Group of Physicans Regarding Latest Advances in Cardiovascular
Risk Assessment
March 19, 2013
Pearl Therapeutics Receives Award for
Innovative Co-Suspension Technology
March 14, 2013
Direct Flow Medical® Transcatheter
Aortic Valve System Demonstrates Excellent Six-Month Outcomes In
Discover Trial
March 12, 2013
Array Biopharma and Global Blood
Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
March 5, 2013
AccessClosure, Inc. Launches MynxGrip™
Vascular Closure Device
February 27, 2013
ReShape Medical Completes
Enrollment of Pivotal Clinical Trial for Weight Loss Device
February 25, 2013
Durata Therapeutics Announces
Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in
the Treatment of ABSSSI
February 25, 2013
NxStage Announces CE Mark Approval,
First Clinical Use of its Single Needle for Dialysis Patients
February 25, 2013
Relypsa Enrolls Initial Patient in
Pivotal Phase 3 Program for the Treatment of Hyperkalemia
February 20, 2013
Oxford Immunotec and Lophius
Biosciences sign licensing and collaboration agreements
January 29, 2013
Pearl Therapeutics Strengthens Its
Organization by Hiring Dr. Michael Riebe, an Industry Veteran in
Respiratory Product Development
January 17, 2013
athenahealth to Acquire Mobile Health Leader Epocrates
January 7, 2013
Relypsa Announces Agreement with FDA
on Special Protocol Assessment for Patiromer Phase 3 Trial for the
Treatment of Hyperkalemia
January 2, 2013
|